MetaCap

MaxCyte Quarterly Balance Sheet

NASDAQ: MXCTHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD

1.37+0.09 (+7.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MaxCyte financial position

As of Sep 30, 2026, MaxCyte reported total assets of $182.5 million, down 14.5% from a year earlier against total liabilities of $31.6 million. Shareholders' equity stood at $150.9 million, or 82.7% of assets. The company held $13.4 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 7.83, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

MaxCyte balance sheet (quarterly)

MaxCyte quarterly balance sheet
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31
Cash & Equivalents13.37M15.04M14.56M20.07M12.97M15.22M23.39M27.88M36.96M37.51M22.25M46.51M
Short-Term Investments87.91M90.65M92.30M82.98M92.75M111.34M114.89M126.60M116.87M119.82M135.26M121.78M
Receivables12.05M3.92M4.25M3.50M8.31M5.75M5.53M4.68M4.56M4.58M5.99M5.78M
Inventory7.38M7.80M7.63M7.55M7.61M7.93M8.27M8.91M10.39M11.16M11.96M12.23M
Total Current Assets124.67M121.27M122.94M118.37M124.64M143.22M155.75M171.68M172.91M175.65M178.67M190.19M
Property, Plant & Equipment14.34M14.90M16.64M17.53M18.62M19.40M19.92M19.71M20.97M21.72M22.80M23.51M
Goodwill————3.55M3.75M3.92M—————
Intangible Assets749.00K766.00K783.00K650.00K667.00K638.00K498.00K—————
Long-Term Investments31.47M36.23M40.81M52.57M52.27M38.60M36.42M35.78M42.80M42.48M45.03M42.94M
Total Assets182.48M184.67M194.47M202.51M213.48M219.75M229.96M239.47M248.61M251.50M257.93M268.27M
Accounts Payable1.03M1.73M1.20M1.40M1.29M1.21M2.28M1.36M1.86M953.00K1.67M743.00K
Total Current Liabilities15.92M9.89M10.21M14.27M16.10M11.55M12.73M15.78M17.62M12.28M13.48M17.86M
Total Liabilities31.55M25.92M26.59M31.02M33.20M29.03M30.55M33.22M35.31M30.23M31.57M36.11M
Shareholders' Equity150.93M158.75M167.89M171.49M180.28M190.72M199.41M206.25M213.30M221.26M226.36M232.17M
Retained Earnings-279.87M-275.11M-266.23M-261.48M-251.89M-239.47M-227.11M-216.85M-206.26M-194.70M-185.32M-175.80M
Net Cash (Debt)101.28M105.69M106.85M103.04M105.73M126.56M138.27M154.48M153.83M157.33M157.51M168.29M
Shares Outstanding103.23M106.13M107.12M106.79M106.64M106.59M106.31M105.71M105.30M104.82M104.41M103.96M

This table shows 12 quarterly periods of MaxCyte's balance sheet, from Q3 2026 back to Q4 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow MXCT's reporting calendar. What is a balance sheet?

More financial data